Treatment
For many patients with chronic orofacial pain, carefully selected medications and supplements play an important supporting role alongside physical treatments. Our approach is conservative, evidence-based, and always tailored to the individual — we prescribe only what is necessary, at the lowest effective dose, for the shortest appropriate duration.
Our Philosophy
Medications and supplements are never our first line of treatment — and they are never used in isolation. They are most effective when integrated with physical treatments such as splint therapy, laser therapy, and trigger point injections, and with behavioural strategies to address contributing factors.
Chronic orofacial pain is complex. In some patients, pain has become centralised — meaning the nervous system itself has become sensitised and amplifies pain signals. In these cases, medications that modulate central pain processing can make a significant difference to quality of life.
We take the time to understand your full medical history, current medications, and lifestyle before making any pharmacological recommendations. Safety and appropriateness are always our first consideration.
Conditions
Pharmacological Options
The following medications may be considered as part of a comprehensive pain management plan. All prescribing decisions are made on an individual basis following a thorough clinical assessment.
Non-steroidal anti-inflammatory drugs reduce inflammation and pain in the jaw joint and surrounding muscles. Used short-term for acute flare-ups of TMJ pain and myofascial conditions.
Note: Short-term use only. Not suitable for patients with gastric, renal, or cardiovascular concerns.
Topical NSAID gels applied directly to the jaw and temple area can provide localised relief with minimal systemic absorption — a useful option for patients who cannot tolerate oral NSAIDs.
Note: Lower systemic side effect profile than oral NSAIDs.
Used short-term to reduce jaw muscle hyperactivity, relieve acute muscle spasm, and improve sleep quality in patients with severe bruxism or myofascial pain. Typically prescribed for 1–2 week courses.
Note: May cause drowsiness. Not suitable for long-term use.
At sub-antidepressant doses, tricyclics are well-established for chronic orofacial pain, neuropathic pain, and sleep disturbance. They reduce central pain sensitisation and improve sleep architecture.
Note: Used at doses far below those used for depression. Taken at night. Requires gradual titration.
For patients with neuropathic or centrally sensitised facial pain, gabapentinoids can reduce pain signalling and improve quality of life when other treatments have been insufficient.
Note: Requires careful titration. Not a first-line treatment — used in selected cases.
Occasionally used short-term for acute jaw muscle spasm or severe sleep disruption from pain. Prescribed conservatively given the risk of dependence.
Note: Short-term use only. Not appropriate for patients with sleep apnoea.
Important: All medications listed above require a clinical assessment and prescription from our specialist/expert clinicians. We do not prescribe medications without a consultation. This information is provided for educational purposes only and does not constitute medical advice.
Nutritional Support
Certain nutritional supplements have good evidence for supporting pain management, muscle function, nerve health, and sleep quality. We recommend supplements based on your individual clinical picture — not as a blanket protocol.
Magnesium plays a key role in muscle relaxation and nerve function. Deficiency is common and associated with increased muscle tension, bruxism, and headache frequency. Supplementation is safe, well-tolerated, and often beneficial for patients with jaw clenching and tension-type headaches.
Good evidence for muscle relaxation and headache prevention.
CoQ10 supports mitochondrial energy production in muscle tissue. Some evidence suggests benefit for patients with myofascial pain and fatigue, particularly those on statin medications (which deplete CoQ10).
Emerging evidence for myofascial pain and fatigue.
Vitamin D deficiency is highly prevalent in Australia despite our sunny climate, and is associated with chronic musculoskeletal pain, increased pain sensitivity, and poor sleep quality. Testing and correction of deficiency is a simple, low-risk intervention.
Strong evidence linking deficiency to chronic pain and poor sleep.
B vitamins — particularly B1, B6, and B12 — support nerve health and are used as adjuncts in the management of neuropathic and chronic orofacial pain. B12 deficiency in particular can contribute to nerve pain.
Supportive evidence for neuropathic pain management.
Low-dose melatonin supports sleep onset and quality without the risks of pharmaceutical sleep aids. Useful for patients whose pain disrupts sleep, and for resetting circadian rhythm in shift workers or frequent travellers.
Well-established for sleep quality. Emerging evidence for pain modulation.
Omega-3s (EPA and DHA) have anti-inflammatory properties and may help reduce chronic inflammatory pain. They are a safe, well-tolerated adjunct for patients with inflammatory joint conditions including TMJ arthritis.
Good evidence for anti-inflammatory effects in chronic pain.
Combined Approach
Medications and supplements work best as part of a broader treatment plan. These are the physical treatments most commonly combined with pharmacological management.
Book a specialist consultation at our Kingston, Canberra clinic. No referral required.